Redox drug derivatives
The present invention provides redox drug derivatives. In particular, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, (3R,4R,5S)-4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester, (3S)-3-(aminomethyl)-5-methylhexanoic acid, (3S)-1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α-α-diphenyl-3-pyrrolidineacetamide, (1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethyl-butyl]-4-(diaminomethylideneamino)-2-hydroxy-cyclopentane-1-carboxylic acid and (2R,3R,4S)-4-[(diaminomethylidene)amino]-3-acetamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid redox derivatives.
1. A compound of formula (III):
wherein:
each R 23 is independently selected from the group consisting of: —H, —F and C 1-3 alkyl;
R 21 is selected from the group consisting of: —NRR′,
and
R 22 is selected from the group consisting of: —CHO, —CH═NOR′″ and
wherein:
—Y— is selected from the group consisting of: ═N—, —O— and —S—;
—Y′— is selected from the group consisting of: —O— and —S—;
(i) each R and R′ is independently selected from the group consisting of: —H and C 1-4 alkyl; or (ii) —NRR′ represents a ring independently selected from the group consisting of: pyrrole, pyrroline, pyrrolidine, piperazine, piperidine, morpholine, azepane, azepine, diazepine, thiazepine and azocane, or (iii)
represents a ring independently selected from the group consisting of: dioxolane, dioxane, dithiolane and dithiane; and
R′″ is selected from the group consisting of: H, C 1-4 alkyl and —(CR″″R″″) n -aryl; wherein R″″ is selected from the group consisting of: H and aryl and wherein n is from 1 to 4.
2. The compound of claim 1 , wherein R 21 is —NH 2 and each R 23 is H.
3. The compound of claim 1 , wherein R 22 is —CHO, —CH═NOH or
4. The compound of claim 2 , wherein R 22 is —CHO, —CH═NOH or
5. A compound of formula (III):
wherein the compound is